The High-Dose Aldesleukin (IL-2) "Select" Trial for Patients With Metastatic Renal Cell Carcinoma
Clinical trial NCT00554515 · COMPLETED
Trial details
- NCT number
- NCT00554515
- Sponsor
- Beth Israel Deaconess Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2013-10-31
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.